Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this interesting learning session on first line management of ALK positive lung cancer.
In this webinar, a panel discussion would take place involving Dr. Jessicca Lin as the primary speaker and Dr. T. Raja, Dr. Amit Rauthan, Dr. B. K. Smruti and many other panelists who will share the important facts associated with first line management of ALK positive lung cancer.
Starting with the case scenario of non-small cell lung cancer, Dr Jessica has explained all details associated with the incidence, progression and treatment of ALK positive lung cancer. Further, the panel discussion will give more knowledge.
ALK-positive lung cancer represents about 4% of lung cancer which generally appears in adenocarcinoma non-small cell lung cancer. Patients with ALK-positive are mostly younger than the average lung cancer patient and also do not have a smoking history compared to other lung cancers.
Therefore, you are going to have an overall knowledge regarding management of ALK positive lung cancer. Listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Childhood cancer survivors face new health problems later in life, study shows
2.
FDA Approves Subcutaneous Isatuximab for MM Indications
3.
Research finds low uptake of supportive care at the end-of-life for patients with advanced cancer
4.
Cancer tumor anatomy influences the benefits of chemotherapy for patients with early-stage breast cancer.
5.
Every cancer is different because of how evolution causes drug resistance and why various cancers require various treatments.
1.
Integrated Techniques in Oncology in the Digital Era
2.
Refining AML Survival: Prognostic Factors, Therapies, and Stem Cell Strategies Reviewed
3.
The Latest Research on Basal Cell Carcinoma: New Developments in Diagnosis and Cure
4.
From Autoimmune Disorders to COVID-19: How Plasmapheresis Is Revolutionizing Modern Medicine
5.
Unveiling the Secrets of Early Cancer: Emerging Strategies to Decipher Its Biology
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
2.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
3.
Thromboprophylaxis In Medical Settings- An Update
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation